Behcet disease and the emergence of thalidomide

被引：24

作者：

Ehrlich, GE ^{[1
]}

机构：

[1] Univ Penn, Philadelphia, PA 19106 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1998年 / 128卷 / 06期

关键词：

D O I：

10.7326/0003-4819-128-6-199803150-00011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：494 / 495

页数：2

共 19 条

[1]

Dilsen N, 1996, REV RHUM, V63, P512

[2]

Ehrlich G E, 1997, Int Rev Immunol, V14, P81, DOI 10.3109/08830189709116846

[3]

EHRLICH GE, 1994, BRAZILIAN J RHEUMATO, V34, P220

[4]

EHRLICH GE, 1975, INFLAMMATION, V1, P223

[5] Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial [J].

Hamuryudan, V ;

Mat, C ;

Saip, S ;

Ozyazgan, Y ;

Siva, A ;

Yurdakul, S ;

Zwingenberger, K ;

Yazici, H .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) :443-+

[6]

Heymann R E, 1995, Rev Rhum Engl Ed, V62, P343

[7] Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection [J].

Jacobson, JM ;

Greenspan, JS ;

Spritzler, J ;

Ketter, N ;

Fahey, JL ;

Jackson, JB ;

Fox, L ;

Chernoff, M ;

Wu, AW ;

MacPhail, LA ;

Vasquez, GJ ;

Wohl, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21) :1487-1493

[8]

Lehner T, 1997, Int Rev Immunol, V14, P21, DOI 10.3109/08830189709116842

[9]

NAKAE KMF, 1993, BEHCETS DIS

[10]

PRCHAL JT, 1973, NEW ENGL J MED, V289, P1146

← 1 2 →